Toxicogenomics: Overview and potential applications for the study of non-covalent DNA interacting chemicals

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 623, Issue 1-2, 2007, Pages 98-108

  Li, Heng Hong ^a   Aubrecht, Jiri ^a,b   Fornace Jr , Albert J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Expression profiling; Gene expression; Genetic toxicology; Intercalators; Toxicogenomics

Indexed keywords

DNA; DNA TOPOISOMERASE; INTERCALATING AGENT;

ARTICLE; CYTOTOXICITY; DNA ADDUCT; DNA CONFORMATION; DNA DAMAGE; GENE EXPRESSION PROFILING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; TOXICOGENETICS;

ANIMALS; DNA; DNA DAMAGE; GENE EXPRESSION PROFILING; HUMANS; MUTAGENS; MUTATION; TOXICOGENETICS;

EID: 34548382555     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.03.013     Document Type: Article

References (86)

1. Muller L., Kikuchi Y., Probst G., Schechtman L., Shimada H., Sofuni T., and Tweats D. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutat. Res. 436 (1999) 195-225
2. Kirkland D., Aardema M., Henderson L., and Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res. 584 (2005) 1-256
3. Snyder R.D., and Green J.W. A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res. 488 (2001) 151-169
4. Henderson L., Albertini S., and Aardema M. Thresholds in genotoxicity responses. Mutat. Res. 464 (2000) 123-128
5. Kirkland D.J., and Muller L. Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds. Mutat. Res. 464 (2000) 137-147
6. Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U., and Decordier I. Indirect mechanisms of genotoxicity. Toxicol. Lett. 140-141 (2003) 63-74
7. 6-alkylguanine. FASEB J. 6 (1992) 2302-2310
8. Snyder R.D., and Hendry L.B. Toward a greater appreciation of non-covalent chemical/DNA interactions: application of biological and computational approaches. Environ. Mol. Mutagen. 45 (2005) 100-105
9. Woynarowski J.M., McHugh M., Sigmund R.D., and Beerman T.A. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4′, 6-diamidine-2-phenylindole. Mol. Pharmacol. 35 (1989) 177-182
10. Kappus H. Oxidative stress in chemical toxicity. Arch. Toxicol. 60 (1987) 144-149
11. Dedon P.C., and Goldberg I.H. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chem. Res. Toxicol. 5 (1992) 311-332
12. Said M.R., Begley T.J., Oppenheim A.V., Lauffenburger D.A., and Samson L.D. Global network analysis of phenotypic effects: protein networks and toxicity modulation in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 18006-18011
13. Weinstein J.N., Kohn K.W., Grever M.R., Viswanadhan V.N., Rubinstein L.V., Monks A.P., Scudiero D.A., Welch L., Koutsoukos A.D., Chiausa A.J., and Paull K.D. Neural computing in cancer drug development: predicting mechanism of action. Science 258 (1992) 447-451
14. Weinstein J.N., and Buolamwini J.K. Molecular targets in cancer drug discovery: cell-based profiling. Curr. Pharm. Des. 6 (2000) 473-483
15. Bakkenist C.J., and Kastan M.B. Initiating cellular stress responses. Cell 118 (2004) 9-17
16. O'Driscoll M., and Jeggo P.A. The role of double-strand break repair-insights from human genetics. Nat. Rev. Genet. 7 (2006) 45-54
17. Amundson S.A., and Fornace Jr. A.J. Complexity of stress signaling and responses. Handbook of Cell Signaling vol. 3 (2003) pp. 179-184
18. Wang W., Ho W.C., Dicker D.T., MacKinnon C., Winkler J.D., Marmorstein R., and El-Deiry W.S. Acridine derivatives activate p53 and induce tumor cell death through Bax. Cancer Biol. Ther. 4 (2005) 893-898
19. Lu H.R., Meng L.H., Huang M., Zhu H., Miao Z.H., and Ding J. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells. Cancer Chemother. Pharmacol. 55 (2005) 286-294
20. Horiguchi-Yamada J., Fukumi S., Saito S., Nakayama R., Iwase S., and Yamada H. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells. Anticancer Res. 22 (2002) 3827-3832
21. Tokino T., Thiagalingam S., el-Deiry W.S., Waldman T., Kinzler K.W., and Vogelstein B. p53 tagged sites from human genomic DNA. Hum. Mol. Genet. 3 (1994) 1537-1542
22. Burns T.F., and El-Deiry W.S. Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation. Cancer Biol. Ther. 2 (2003) 431-443
23. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
24. Strekowski L., Strekowska A., Watson R.A., Tanious F.A., Nguyen L.T., and Wilson W.D. Amplification of bleomycin-mediated degradation of DNA. J. Med. Chem. 30 (1987) 1415-1420
25. Snyder R.D., and Strekowski L. Enhancement of bleomycin-induced micronucleus formation in V79 cells as a rapid and sensitive screen for non-covalent DNA-binding compounds. Mutat. Res. 444 (1999) 181-192
26. Snyder R.D., and Diehl M.S. The bleomycin amplification assay in V79 cells predicts frameshift mutagenicity of intercalative agents. Mutagenesis 15 (2000) 203-205
27. Kouzine F., Liu J., Sanford S., Chung H.J., and Levens D. The dynamic response of upstream DNA to transcription-generated torsional stress. Nat. Struct. Mol. Biol. 11 (2004) 1092-1100
28. Liu J., Kouzine F., Nie Z., Chung H.J., Elisha-Feil Z., Weber A., Zhao K., and Levens D. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J. 25 (2006) 2119-2130
29. Welch J.J., Rauscher Jr. F., and Beerman T.A. Targeting DNA-binding drugs to sequence-specific transcription factor. DNA complexes. Differential effects of intercalating and minor groove binding drugs. J. Biol. Chem. 269 (1994) 31051-31058
30. Nguyen-Hackley D.H., Ramm E., Taylor C.M., Joung J.K., Dervan P.B., and Pabo C.O. Allosteric inhibition of zinc-finger binding in the major groove of DNA by minor-groove binding ligands. Biochemistry 43 (2004) 3880-3890
31. Gearhart M.D., Dickinson L., Ehley J., Melander C., Dervan P.B., Wright P.E., and Gottesfeld J.M. Inhibition of DNA binding by human estrogen-related receptor 2 and estrogen receptor alpha with minor groove binding polyamides. Biochemistry 44 (2005) 4196-4203
32. Hayakawa T., Noda M., Yasuda K., Yorifuji H., Taniguchi S., Miwa I., Sakura H., Terauchi Y., Hayashi J., Sharp G.W., Kanazawa Y., Akanuma Y., Yazaki Y., and Kadowaki T. Ethidium bromide-induced inhibition of mitochondrial gene transcription suppresses glucose-stimulated insulin release in the mouse pancreatic beta-cell line betaHC9. J. Biol. Chem. 273 (1998) 20300-20307
33. Cahill P.A., Knight A.W., Billinton N., Barker M.G., Walsh L., Keenan P.O., Williams C.V., Tweats D.J., and Walmsley R.M. The GreenScreen genotoxicity assay: a screening validation programme. Mutagenesis 19 (2004) 105-119
34. Oda Y., Nakamura S., Oki I., Kato T., and Shinagawa H. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat. Res. 147 (1985) 219-229
35. Quillardet P., and Hofnung M. The SOS chromotest: a review. Mutat. Res. 297 (1993) 235-279
36. van der Lelie D., Regniers L., Borremans B., Provoost A., and Verschaeve L. The VITOTOX test, an SOS bioluminescence Salmonella typhimurium test to measure genotoxicity kinetics. Mutat. Res. 389 (1997) 279-290
37. Fornace Jr. A.J., Alamo I.J., and Hollander M.C. DNA damage-inducible transcripts in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 8800-8804
38. Fornace Jr. A.J., Jackman J., Hollander M.C., Hoffman-Liebermann B., and Liebermann D.A. Genotoxic-stress-response genes and growth-arrest genes; the gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann. NY Acad. Sci. 663 (1992) 139-153
39. Liu Z.G., Baskaran R., Lea-Chou E.T., Wood L.D., Chen Y., Karin M., and Wang J.Y. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384 (1996) 273-276
40. Hastwell P.W., Chai L.L., Roberts K.J., Webster T.W., Harvey J.S., Rees R.W., and Walmsley R.M. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat. Res. 607 (2006) 160-175
41. Todd M.D., Lee M.J., Williams J.L., Nalezny J.M., Gee P., Benjamin M.B., and Farr S.B. The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam. Appl. Toxicol. 28 (1995) 118-128
42. Yang J., and Duerksen-Hughes P. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis 19 (1998) 1117-1125
43. Duerksen-Hughes P.J., Yang J., and Ozcan O. p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing. Environ. Health Perspect. 107 (1999) 805-812
44. Amundson S.A., Myers T.G., and Fornace Jr. A.J. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17 (1998) 3287-3300
45. Ko L.J., and Prives C. p53: puzzle and paradigm. Genes Dev. 10 (1996) 1054-1072
46. Lopes U.G., Erhardt P., Yao R., and Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272 (1997) 12893-12896
47. Aubrecht J., Narla R.K., Ghosh P., Stanek J., and Uckun F.M. Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes. Toxicol. Appl. Pharmacol. 154 (1999) 228-235
48. Vincent R., Goegan P., Johnson G., Brook J.R., Kumarathasan P., Bouthillier L., and Burnett R.T. Regulation of promoter-CAT stress genes in HepG2 cells by suspensions of particles from ambient air. Fundam. Appl. Toxicol. 39 (1997) 18-32
49. Sutton M.D., Smith B.T., Godoy V.G., and Walker G.C. The SOS response: recent insights into umuDC-dependent mutagenesis and DNA damage tolerance. Annu. Rev. Genet. 34 (2000) 479-497
50. Birrell G.W., Brown J.A., Wu H.I., Giaever G., Chu A.M., Davis R.W., and Brown J.M. Transcriptional response of Saccharomyces cerevisiae to DNA damaging agents does not identify the genes that protect against these agents. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8778-8783
51. Ruby S.W., and Szostak J.W. Specific Saccharomyces cerevisiae genes are expressed in response to DNA damaging agents. Mol. Cell Biol. 5 (1985) 75-84
52. Amundson S.A., Patterson A., Do K.T., and Fornace Jr. A.J. A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther. 1 (2002) 145-149
53. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
54. Snyder A.R., and Morgan W.F. Gene expression profiling after irradiation: clues to understanding acute and persistent responses?. Cancer Metastasis Rev. 23 (2004) 259-268
55. Amundson S.A., Bittner M., and Fornace Jr. A.J. Functional genomics as a window on radiation stress signaling. Oncogene 22 (2003) 5828-5833
56. Saito S., Yamaguchi H., Higashimoto Y., Chao C., Xu Y., Fornace Jr. A.J., Appella E., and Anderson C.W. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278 (2003) 37536-37544
57. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., Kallioniemi A., Fornace Jr. A.J., and Appella E. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31 (2002) 210-215
58. Amundson S.A., Do K.T., Shahab S., Bittner M., Meltzer P., Trent J., and Fornace Jr. A.J. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat. Res. 154 (2000) 342-346
59. Amundson S.A., Do K.T., and Fornace Jr. A.J. Induction of stress genes by low doses of gamma rays. Radiat. Res. 152 (1999) 225-231
60. Coleman M.A., Yin E., Peterson L.E., Nelson D., Sorensen K., Tucker J.D., and Wyrobek A.J. Low-dose irradiation alters the transcript profiles of human lymphoblastoid cells including genes associated with cytogenetic radioadaptive response. Radiat. Res. 164 (2005) 369-382
61. Rouse J., and Jackson S.P. Interfaces between the detection, signaling, and repair of DNA damage. Science 297 (2002) 547-551
62. Amundson S.A., Do K.T., Vinikoor L., Koch-Paiz C.A., Bittner M.L., Trent J.M., Meltzer P., and Fornace Jr. A.J. Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene 24 (2005) 4572-4579
63. Amundson S.A., Grace M.B., McLeland C.B., Epperly M.W., Yeager A., Greenberger J.S., and Fornace Jr. A.J. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res. 64 (2004) 6368-6371
64. Powell C.L., Kosyk O., Ross P.K., Schoonhoven R., Boysen G., Swenberg J.A., Heinloth A.N., Boorman G.A., Cunningham M.L., Paules R.S., and Rusyn I. Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol. Sci. 93 (2006) 213-222
65. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
66. Amundson S.A., Bittner M., Chen Y.D., Trent J., Meltzer P., and Fornace Jr. A.J. cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18 (1999) 3666-3672
67. Fornace Jr. A.J., Amundson S.A., Bittner M., Myers T.G., Meltzer P., Weinstein J.N., and Trent J. The complexity of radiation stress responses: analysis by informatics and functional genomics approaches. Gene Expr. 7 (1999) 387-400
68. Hughes T.R., Marton M.J., Jones A.R., Roberts C.J., Stoughton R., Armour C.D., Bennett H.A., Coffey E., Dai H., He Y.D., Kidd M.J., King A.M., Meyer M.R., Slade D., Lum P.Y., Stepaniants S.B., Shoemaker D.D., Gachotte D., Chakraburtty K., Simon J., Bard M., and Friend S.H. Functional discovery via a compendium of expression profiles. Cell 102 (2000) 109-126
69. Jelinsky S.A., Estep P., Church G.M., and Samson L.D. Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol. Cell Biol. 20 (2000) 8157-8167
70. Caba E., Dickinson D.A., Warnes G.R., and Aubrecht J. Differentiating mechanisms of toxicity using global gene expression analysis in Saccharomyces cerevisiae. Mutat. Res. 575 (2005) 34-46
71. Aubrecht J., and Caba E. Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity. Pharmacogenomics 6 (2005) 419-428
72. Irwin R.D., Boorman G.A., Cunningham M.L., Heinloth A.N., Malarkey D.E., and Paules R.S. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data. Toxicol. Pathol. 32 Suppl. 1 (2004) 72-83
73. Kier L.D., Neft R., Tang L., Suizu R., Cook T., Onsurez K., Tiegler K., Sakai Y., Ortiz M., Nolan T., Sankar U., and Li A.P. Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. Mutat. Res. 549 (2004) 101-113
74. Hamadeh H.K., Bushel P.R., Jayadev S., DiSorbo O., Bennett L., Li L., Tennant R., Stoll R., Barrett J.C., Paules R.S., Blanchard K., and Afshari C.A. Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. 67 (2002) 232-240
75. Natsoulis G., El Ghaoui L., Lanckriet G.R., Tolley A.M., Leroy F., Dunlea S., Eynon B.P., Pearson C.I., Tugendreich S., and Jarnagin K. Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res. 15 (2005) 724-736
76. Rockett J.C., Burczynski M.E., Fornace Jr. A.J., Herrmann P.C., Krawetz S.A., and Dix D.J. Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells. Toxicol. Appl. Pharmacol. 194 (2004) 189-199
77. van Delft J.H., van Agen E., van Breda S.G., Herwijnen M.H., Staal Y.C., and Kleinjans J.C. Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis 25 (2004) 1265-1276
78. Islaih M., Li B., Kadura I.A., Reid-Hubbard J.L., Deahl J.T., Altizer J.L., Watson D.E., and Newton R.K. Comparison of gene expression changes induced in mouse and human cells treated with direct-acting mutagens. Environ. Mol. Mutagen. 44 (2004) 401-419
79. Dickinson D.A., Warnes G.R., Quievryn G., Messer J., Zhitkovich A., Rubitski E., and Aubrecht J. Differentiation of DNA reactive and non-reactive genotoxic mechanisms using gene expression profile analysis. Mutat. Res. 549 (2004) 29-41
80. Hu T., Gibson D.P., Carr G.J., Torontali S.M., Tiesman J.P., Chaney J.G., and Aardema M.J. Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mutat. Res. 549 (2004) 5-27
81. Lim J.H., Lee J.I., Suh Y.H., Kim W., Song J.H., and Jung M.H. Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilization in murine C2C12 myotube cells. Diabetologia 49 (2006) 1924-1936
82. Behan A., Doyle S., and Farrell M. Adaptive responses to mitochondrial dysfunction in the rho degrees Namalwa cell. Mitochondrion 5 (2005) 173-193
83. Islaih M., Halstead B.W., Kadura I.A., Li B., Reid-Hubbard J.L., Flick L., Altizer J.L., Thom Deahl J., Monteith D.K., Newton R.K., and Watson D.E. Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals. Mutat. Res. 578 (2005) 100-116
84. Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., Lerner J., Brunet J.P., Subramanian A., Ross K.N., Reich M., Hieronymus H., Wei G., Armstrong S.A., Haggarty S.J., Clemons P.A., Wei R., Carr S.A., Lander E.S., and Golub T.R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313 (2006) 1929-1935
85. van Osdol W.W., My T.G., ers K.D., Paull K.W., Kohn J.N., and Weinstein. Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents. J. Natl. Cancer Inst. 86 (1994) 1853-1859
86. Amundson S.A., Myers T.G., Scudiero D., Kitada S., Reed J.C., and Fornace Jr. A.J. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60 (2000) 6101-6110